Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/7/26 16:41 | 7/6/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Townson Sharon | MA | O | Chief Sc | 4 | S.d | -376 | 20.89 | 0 | -18 | 68 | D | |||||||||||||||
7/1/26 16:57 | 6/30/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Janku Filip | MA | O | Chief Me | 3 | S.dm | -1,152 | 21.64 | 0 | -53 | 61 | D | |||||||||||||||
6/30/26 16:05 | 6/29/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Manning Anthony M. | MA | D | 2 | S.d | -411 | 20.56 | 0 | -20 | -100 | 0 | D | |||||||||||||||
6/25/26 16:05 | 6/23/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Champoux Jennifer | MA | O | COO | 4 | S.d | -170 | 19.50 | 0 | -9 | 62 | D | |||||||||||||||
6/2/26 16:05 | 6/1/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Warmuth Markus | MA | DO | P,CEO | 3 | S | -351 | 18.53 | 0 | -19 | 605 | D | |||||||||||||||
4/10/26 16:07 | 4/9/26 | GLUE | Health | BioPrd | Biological Products, (No Diag | Nickson Philip | MA | O | Chief Bu | 1 | S | -103 | 17.69 | 0 | -6 | 55 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |